Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
Venus Medtech acquires Cardiovalve
Venus Medtech acquired Israeli company Cardiovalve for $300 million, according to a joint statement by the two companies. The stated purpose was to expand Venus Medtech's valve-replacement product portfolio and accelerate innovation and internationalization.
2021
Venus Medtech announces acquisition of Cardiovalve
Venus Medtech announced that it would acquire 100% of Cardiovalve's equity for $300 million, with payment in installments subject to agreed milestones.